Victory Capital Management
ALDR

Victory Capital Management’s Alder Biopharmaceuticals ALDR Stock Holding History

Victory Capital Management’s Portfolio ALDR Stock Details ALDR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-11,728
Closed -$221K – 3750
2019
Q3 		$221K Buy
+11,728
New +$134K ﹤0.01% 2190

Victory Capital Management's ALDR Position: Q4 2019 in Review

Victory Capital Management sold out of Alder Biopharmaceuticals (ALDR) in Q4 2019, closing a stake of 11,728 shares — an estimated $221K sold.

Victory Capital Management first reported a position in ALDR in Q3 2019 and held it in 1 quarter. The position peaked at $221K in Q3 2019. 0 funds tracked by Wall St. Rank hold ALDR as of Q4 2019.

  • Victory Capital Management reported no remaining Alder Biopharmaceuticals position as of Q4 2019 after selling out during the quarter.
  • Victory Capital Management sold 11,728 Alder Biopharmaceuticals shares in Q4 2019, an estimated $221K.
  • Victory Capital Management first reported a position in Alder Biopharmaceuticals in Q3 2019 and held it in 1 quarter.
  • Victory Capital Management's Alder Biopharmaceuticals position peaked at $221K in Q3 2019.
  • 0 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q4 2019.

Based on Victory Capital Management's 13F filing for Q4 2019, filed 4 Feb 2020.